Alzamend Neuro Stock Current Valuation
| ALZN Stock | USD 1.26 0.06 5.00% |
Valuation analysis of Alzamend Neuro helps investors to measure Alzamend Neuro's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 5th of January 2025, Enterprise Value Over EBITDA is likely to grow to -0.52. In addition to that, Enterprise Value Multiple is likely to grow to -0.52. Fundamental drivers impacting Alzamend Neuro's valuation include:
Overvalued
Today
Please note that Alzamend Neuro's price fluctuation is dangerous at this time. Calculation of the real value of Alzamend Neuro is based on 3 months time horizon. Increasing Alzamend Neuro's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Alzamend Neuro is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alzamend Stock. However, Alzamend Neuro's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.26 | Real 1.13 | Target 32.0 | Hype 1.26 | Naive 1.23 |
The intrinsic value of Alzamend Neuro's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alzamend Neuro's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alzamend Neuro helps investors to forecast how Alzamend stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alzamend Neuro more accurately as focusing exclusively on Alzamend Neuro's fundamentals will not take into account other important factors: Alzamend Neuro Company Current Valuation Analysis
Alzamend Neuro's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Alzamend Neuro Current Valuation | 6.77 M |
Most of Alzamend Neuro's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alzamend Neuro is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Alzamend Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Alzamend Neuro is extremely important. It helps to project a fair market value of Alzamend Stock properly, considering its historical fundamentals such as Current Valuation. Since Alzamend Neuro's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alzamend Neuro's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alzamend Neuro's interrelated accounts and indicators.
Click cells to compare fundamentals
Alzamend Current Valuation Historical Pattern
Today, most investors in Alzamend Neuro Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alzamend Neuro's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Alzamend Neuro current valuation as a starting point in their analysis.
Alzamend Neuro Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Alzamend Neuro has a Current Valuation of 6.77 M. This is 99.95% lower than that of the Biotechnology sector and 99.85% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.96% higher than that of the company.
Alzamend Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alzamend Neuro's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alzamend Neuro could also be used in its relative valuation, which is a method of valuing Alzamend Neuro by comparing valuation metrics of similar companies.Alzamend Neuro is currently under evaluation in current valuation category among its peers.
Alzamend Fundamentals
| Return On Equity | -44.08 | ||||
| Return On Asset | -2.14 | ||||
| Current Valuation | 6.77 M | ||||
| Shares Outstanding | 5.43 M | ||||
| Shares Owned By Insiders | 4.55 % | ||||
| Shares Owned By Institutions | 0.94 % | ||||
| Number Of Shares Shorted | 62.94 K | ||||
| Price To Book | 1.82 X | ||||
| EBITDA | (9.89 M) | ||||
| Net Income | (9.95 M) | ||||
| Cash And Equivalents | 11.53 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 300.71 K | ||||
| Current Ratio | 11.78 X | ||||
| Book Value Per Share | (3.77) X | ||||
| Cash Flow From Operations | (8.27 M) | ||||
| Short Ratio | 1.03 X | ||||
| Earnings Per Share | (138.31) X | ||||
| Target Price | 32.0 | ||||
| Beta | -0.038 | ||||
| Market Capitalization | 6.85 M | ||||
| Total Asset | 631.59 K | ||||
| Retained Earnings | (54.02 M) | ||||
| Working Capital | (2.77 M) | ||||
| Net Asset | 631.59 K |
About Alzamend Neuro Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alzamend Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alzamend Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alzamend Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Alzamend Neuro offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alzamend Neuro's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alzamend Neuro Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alzamend Neuro Stock: Check out Alzamend Neuro Piotroski F Score and Alzamend Neuro Altman Z Score analysis. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.